The melanin-concentrating hormone system modulates cocaine reward.

Common cellular and molecular mechanisms in obesity and drug addiction. Nat Rev Neurosci (2011) 1.93

Fos activation of selective afferents to ventral tegmental area during cue-induced reinstatement of cocaine seeking in rats. J Neurosci (2012) 1.79

Caloric restriction experience reprograms stress and orexigenic pathways and promotes binge eating. J Neurosci (2010) 1.77

Role of CRF and other neuropeptides in stress-induced reinstatement of drug seeking. Brain Res (2009) 1.42

The drive to eat: comparisons and distinctions between mechanisms of food reward and drug addiction. Nat Neurosci (2012) 1.33

The role of hypocretin in driving arousal and goal-oriented behaviors. Brain Res (2009) 1.25

Regulation of nucleus accumbens activity by the hypothalamic neuropeptide melanin-concentrating hormone. J Neurosci (2010) 1.13

A septal-hypothalamic pathway drives orexin neurons, which is necessary for conditioned cocaine preference. J Neurosci (2012) 1.13

A confirmed case of agranulocytosis after use of cocaine contaminated with levamisole. J Med Toxicol (2010) 1.10

The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders. Psychopharmacology (Berl) (2013) 1.02

Recent updates on the melanin-concentrating hormone (MCH) and its receptor system: lessons from MCH1R antagonists. J Mol Neurosci (2010) 0.98

Ablation of neurons expressing melanin-concentrating hormone (MCH) in adult mice improves glucose tolerance independent of MCH signaling. J Neurosci (2013) 0.97

Brain regulation of energy balance and body weight. Rev Endocr Metab Disord (2013) 0.96

A comparative analysis shows morphofunctional differences between the rat and mouse melanin-concentrating hormone systems. PLoS One (2010) 0.93

Role of melanin-concentrating hormone in the control of ethanol consumption: Region-specific effects revealed by expression and injection studies. Physiol Behav (2010) 0.92

Suppression of alcohol self-administration and reinstatement of alcohol seeking by melanin-concentrating hormone receptor 1 (MCH1-R) antagonism in Wistar rats. Psychopharmacology (Berl) (2010) 0.92

The melanin-concentrating hormone (MCH) system in an animal model of depression-like behavior. Eur Neuropsychopharmacol (2011) 0.91

Investigation of the neuroanatomical substrates of reward seeking following protracted abstinence in mice. J Physiol (2012) 0.90

Lateral thinking about leptin: a review of leptin action via the lateral hypothalamus. Physiol Behav (2011) 0.88

Food restriction increases acquisition, persistence and drug prime-induced expression of a cocaine-conditioned place preference in rats. Pharmacol Biochem Behav (2011) 0.87

Role of cues and contexts on drug-seeking behaviour. Br J Pharmacol (2014) 0.87

Mice lacking the galanin gene show decreased sensitivity to nicotine conditioned place preference. Pharmacol Biochem Behav (2010) 0.87

To ingest or rest? Specialized roles of lateral hypothalamic area neurons in coordinating energy balance. Front Syst Neurosci (2015) 0.85

Chronic loss of melanin-concentrating hormone affects motivational aspects of feeding in the rat. PLoS One (2011) 0.85

The melanin-concentrating hormone (MCH) system modulates behaviors associated with psychiatric disorders. PLoS One (2011) 0.85

Cocaine potentiates excitatory drive in the perifornical/lateral hypothalamus. J Physiol (2012) 0.84

Locomotion and self-administration induced by cocaine in 129/OlaHsd mice lacking galanin. Behav Neurosci (2010) 0.82

Development of posterior hypothalamic neurons enlightens a switch in the prosencephalic basic plan. PLoS One (2011) 0.81

Histamine inhibits the melanin-concentrating hormone system: implications for sleep and arousal. J Physiol (2014) 0.80

Increased orexin and melanin-concentrating hormone expression in the perifornical lateral hypothalamus of rats prone to overconsuming a fat-rich diet. Pharmacol Biochem Behav (2010) 0.80

Hubs and spokes of the lateral hypothalamus: cell types, circuits and behaviour. J Physiol (2016) 0.79

Peripheral injections of melanin-concentrating hormone receptor 1 antagonist S38151 decrease food intake and body weight in rodent obesity models. Front Endocrinol (Lausanne) (2012) 0.77

MCH and apomorphine in combination enhance action potential firing of nucleus accumbens shell neurons in vitro. PeerJ (2013) 0.77

Identification of neuropeptide receptors expressed by melanin-concentrating hormone neurons. J Comp Neurol (2014) 0.77

Anxiolytic effects of the MCH1R antagonist TPI 1361-17. J Mol Neurosci (2010) 0.76

Mice lacking Melanin Concentrating Hormone 1 receptor are resistant to seizures. Neurosci Lett (2010) 0.76

Intra-ventral tegmental area microinjections of urotensin II modulate the effects of cocaine. Behav Brain Res (2014) 0.75

mTOR signalling in the nucleus accumbens shell is critical for augmented effect of TFF3 on behavioural response to cocaine. Sci Rep (2016) 0.75

The melanin-concentrating hormone-1 receptor modulates alcohol-induced reward and DARPP-32 phosphorylation. Psychopharmacology (Berl) (2016) 0.75

Interactions of Circadian Rhythmicity, Stress and Orexigenic Neuropeptide Systems: Implications for Food Intake Control. Front Neurosci (2017) 0.75

Disruption of the melanin-concentrating hormone receptor 1 (MCH1R) affects thyroid function. Endocrinology (2012) 0.75

Novel Neuroprotective Effects of Melanin-Concentrating Hormone in Parkinson's Disease. Mol Neurobiol (2016) 0.75

The Melanin-Concentrating Hormone as an Integrative Peptide Driving Motivated Behaviors. Front Syst Neurosci (2017) 0.75

Effects of nicotine on homeostatic and hedonic components of food intake. J Endocrinol (2017) 0.75

Hunger and Satiety Gauge Reward Sensitivity. Front Endocrinol (Lausanne) (2017) 0.75

Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell (1998) 12.66

Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Methods (1996) 6.41

The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry (2007) 4.51

The neurobiology of slow synaptic transmission. Science (2001) 3.97

A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature (1996) 3.79

Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects. Neuron (2004) 3.61

Nucleus accumbens shell and core dopamine: differential role in behavior and addiction. Behav Brain Res (2002) 3.55

The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization. J Comp Neurol (1992) 3.53

Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons. Nature (1999) 3.50

Stress-induced relapse to heroin and cocaine seeking in rats: a review. Brain Res Brain Res Rev (2000) 3.40

Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. J Neurosci (1996) 2.89

Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J Neurosci (1998) 2.72

Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist. Nat Med (2002) 2.60

Expression of the melanin-concentrating hormone (MCH) receptor mRNA in the rat brain. J Comp Neurol (2001) 2.45

Bidirectional regulation of DARPP-32 phosphorylation by dopamine. J Neurosci (1997) 2.17

Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism. Proc Natl Acad Sci U S A (2002) 2.00

Molecular characterization of the melanin-concentrating-hormone receptor. Nature (1999) 2.00

Pathways to relapse: the neurobiology of drug- and stress-induced relapse to drug-taking. J Psychiatry Neurosci (2000) 1.96

The hypothalamic neuropeptide melanin-concentrating hormone acts in the nucleus accumbens to modulate feeding behavior and forced-swim performance. J Neurosci (2005) 1.86

Characterization of melanin-concentrating hormone in chum salmon pituitaries. Nature (1983) 1.79

Self-stimulation of the brain; its use to study local effects of hunger, sex, and drugs. Science (1958) 1.72

Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1. Nature (1999) 1.68

DARPP-32 mediates the actions of multiple drugs of abuse. AAPS J (2005) 1.66

Pharmacological blockade of alpha2-adrenoceptors induces reinstatement of cocaine-seeking behavior in squirrel monkeys. Neuropsychopharmacology (2004) 1.62

Critical assessment of how to study addiction and its treatment: human and non-human animal models. Pharmacol Ther (2005) 1.59

Role of dopamine D1 and D2 receptors in the nucleus accumbens in mediating reward. J Neurosci (1997) 1.55

The role of neuroadaptations in relapse to drug seeking. Nat Neurosci (2005) 1.51

Expanding the scales: The multiple roles of MCH in regulating energy balance and other biological functions. Endocr Rev (2006) 1.46

The receptor for the orexigenic peptide melanin-concentrating hormone is a G-protein-coupled receptor. Nat Cell Biol (1999) 1.43

Cooperative activation of dopamine D1 and D2 receptors increases spike firing of nucleus accumbens neurons via G-protein betagamma subunits. J Neurosci (2003) 1.38

Identification of melanin concentrating hormone (MCH) as the natural ligand for the orphan somatostatin-like receptor 1 (SLC-1). FEBS Lett (1999) 1.27

Efficacy of the MCHR1 antagonist N-[3-(1-{[4-(3,4-difluorophenoxy)phenyl]methyl}(4-piperidyl))-4-methylphenyl]-2-methylpropanamide (SNAP 94847) in mouse models of anxiety and depression following acute and chronic administration is independent of hippocampal neurogenesis. J Pharmacol Exp Ther (2007) 1.27

Phosphorylation of DARPP-32 at Threonine-34 is required for cocaine action. Neuropsychopharmacology (2006) 1.24

Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat. Neuroscience (2006) 1.23

Cannabinoid CB1 receptor antagonists attenuate cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats. Neuropsychopharmacology (2007) 1.21

The topographic order of inputs to nucleus accumbens in the rat. Neuroscience (1985) 1.20

Isolation and identification of melanin-concentrating hormone as the endogenous ligand of the SLC-1 receptor. Biochem Biophys Res Commun (1999) 1.19

Genetic NMDA receptor deficiency disrupts acute and chronic effects of cocaine but not amphetamine. Neuropsychopharmacology (2008) 1.14

Characterization of melanin-concentrating hormone from rat hypothalamus. Endocrinology (1989) 1.13

Melanin-concentrating hormone-1 receptor modulates neuroendocrine, behavioral, and corticolimbic neurochemical stress responses in mice. Neuropsychopharmacology (2006) 1.06

Mesolimbic dopamine super-sensitivity in melanin-concentrating hormone-1 receptor-deficient mice. J Neurosci (2005) 1.02

Effects of positive allosteric modulators of the GABAB receptor on cocaine self-administration in rats. Psychopharmacology (Berl) (2004) 1.02

Microinjection of the delta-opioid receptor selective antagonist naltrindole 5'-isothiocyanate site specifically affects cocaine self-administration in rats responding under a progressive ratio schedule of reinforcement. Behav Brain Res (2007) 0.93

The pharmacological properties of a novel MCH1 receptor antagonist isolated from combinatorial libraries. Eur J Pharmacol (2008) 0.87

An examination of heroin conditioning in preferred and nonpreferred environments and in differentially housed mature and immature rats. Pharmacol Biochem Behav (1985) 0.86

Mice lacking the melanin-concentrating hormone receptor-1 exhibit an atypical psychomotor susceptibility to cocaine and no conditioned cocaine response. Behav Brain Res (2006) 0.86

Melanin-concentrating hormone in the human brain. Peptides (1993) 0.84

Deletion of Melanin-Concentrating Hormone Receptor-1 gene accentuates D-amphetamine-induced psychomotor activation but neither the subsequent development of sensitization nor the expression of conditioned activity in mice. Pharmacol Biochem Behav (2007) 0.82

Amphetamine- and cocaine-induced conditioned place preference and concomitant psychomotor sensitization in mice with genetically inactivated melanin-concentrating hormone MCH(1) receptor. Eur J Pharmacol (2008) 0.82

Electrophysiological basis of the reinforcing effects of cocaine. Behav Pharmacol (1990) 0.81

Melanin-concentrating hormone (MCH) is colocalized with alpha-melanocyte-stimulating hormone (alpha-MSH) in the rat but not in the human hypothalamus. Brain Res (1987) 0.78

Phasic firing in dopaminergic neurons is sufficient for behavioral conditioning. Science (2009) 8.76

Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron (2003) 6.19

Excitatory transmission from the amygdala to nucleus accumbens facilitates reward seeking. Nature (2011) 4.58

Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron (2006) 4.39

Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects. Neuron (2004) 3.61

Dopaminergic terminals in the nucleus accumbens but not the dorsal striatum corelease glutamate. J Neurosci (2010) 3.47

Synaptic and behavioral profile of multiple glutamatergic inputs to the nucleus accumbens. Neuron (2012) 2.91

Reward-predictive cues enhance excitatory synaptic strength onto midbrain dopamine neurons. Science (2008) 2.82

Corticotropin-releasing factor requires CRF binding protein to potentiate NMDA receptors via CRF receptor 2 in dopamine neurons. Neuron (2003) 2.81

A central role of the BK potassium channel in behavioral responses to ethanol in C. elegans. Cell (2003) 2.72

Cocaine but not natural reward self-administration nor passive cocaine infusion produces persistent LTP in the VTA. Neuron (2008) 2.69

Acute and chronic cocaine-induced potentiation of synaptic strength in the ventral tegmental area: electrophysiological and behavioral correlates in individual rats. J Neurosci (2004) 2.59

Rapid strengthening of thalamo-amygdala synapses mediates cue-reward learning. Nature (2008) 2.47

Role of NMDA receptors in dopamine neurons for plasticity and addictive behaviors. Neuron (2008) 2.41

Optogenetic interrogation of dopaminergic modulation of the multiple phases of reward-seeking behavior. J Neurosci (2011) 2.37

The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference. Nat Neurosci (2004) 2.33

Cocaine self-administration selectively abolishes LTD in the core of the nucleus accumbens. Nat Neurosci (2006) 2.23

Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons. J Neurosci (2003) 2.21

Rescuing cocaine-induced prefrontal cortex hypoactivity prevents compulsive cocaine seeking. Nature (2013) 2.15

Mechanism and time course of cocaine-induced long-term potentiation in the ventral tegmental area. J Neurosci (2008) 2.15

Orexin A/hypocretin-1 selectively promotes motivation for positive reinforcers. J Neurosci (2009) 2.02

Distribution of neuropeptide S receptor mRNA and neurochemical characteristics of neuropeptide S-expressing neurons in the rat brain. J Comp Neurol (2007) 1.95

Inhibition of orexin-1/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long-Evans rats. Psychopharmacology (Berl) (2008) 1.89

Pharmacological characterization of human and murine neuropeptide s receptor variants. J Pharmacol Exp Ther (2005) 1.81

Transient stimulation of distinct subpopulations of striatal neurons mimics changes in action value. Nat Neurosci (2012) 1.79

Chlorzoxazone, an SK-type potassium channel activator used in humans, reduces excessive alcohol intake in rats. Biol Psychiatry (2010) 1.74

Synaptic plasticity and drug addiction. Curr Opin Pharmacol (2005) 1.73

AMPA receptor synaptic plasticity induced by psychostimulants: the past, present, and therapeutic future. Neuron (2010) 1.68

Long-lasting potentiation of GABAergic synapses in dopamine neurons after a single in vivo ethanol exposure. J Neurosci (2002) 1.66

Cocaine enhances NMDA receptor-mediated currents in ventral tegmental area cells via dopamine D5 receptor-dependent redistribution of NMDA receptors. J Neurosci (2006) 1.63

Both kappa and mu opioid agonists inhibit glutamatergic input to ventral tegmental area neurons. J Neurophysiol (2004) 1.62

NMDA receptor function is regulated by the inhibitory scaffolding protein, RACK1. Proc Natl Acad Sci U S A (2002) 1.59

Dopamine responsiveness is regulated by targeted sorting of D2 receptors. Proc Natl Acad Sci U S A (2005) 1.55

Smoking to self-medicate attentional and emotional dysfunctions. Nicotine Tob Res (2007) 1.54

Activation of dopamine neurons is critical for aversive conditioning and prevention of generalized anxiety. Nat Neurosci (2011) 1.46

{N,N-Dimethyl-N'-[phen-yl(2-pyrid-yl)methyl-ene]ethane-1,2-diamine-κN,N',N''}dithio-cyanato-κN,κS-copper(II). Acta Crystallogr Sect E Struct Rep Online (2009) 1.44

Isolation and characterization of a rice WUSCHEL-type homeobox gene that is specifically expressed in the central cells of a quiescent center in the root apical meristem. Plant J (2003) 1.42

Nucleus accumbens AGS3 expression drives ethanol seeking through G betagamma. Proc Natl Acad Sci U S A (2008) 1.41

Poly(A) tail length of neurohypophysial hormones is shortened under endoplasmic reticulum stress. Endocrinology (2011) 1.40

Ectopic expression of KNOTTED1-like homeobox protein induces expression of cytokinin biosynthesis genes in rice. Plant Physiol (2006) 1.39

Cooperative activation of dopamine D1 and D2 receptors increases spike firing of nucleus accumbens neurons via G-protein betagamma subunits. J Neurosci (2003) 1.38

Endocytosis promotes rapid dopaminergic signaling. Neuron (2011) 1.35

Cortical activation of accumbens hyperpolarization-active NMDARs mediates aversion-resistant alcohol intake. Nat Neurosci (2013) 1.35

Acute cocaine exposure alters spine density and long-term potentiation in the ventral tegmental area. Eur J Neurosci (2007) 1.33

C57BL/6N mutation in cytoplasmic FMRP interacting protein 2 regulates cocaine response. Science (2013) 1.31

Dynamic interaction between sigma-1 receptor and Kv1.2 shapes neuronal and behavioral responses to cocaine. Cell (2013) 1.31

Withdrawal from intermittent ethanol exposure increases probability of burst firing in VTA neurons in vitro. J Neurophysiol (2007) 1.30

Similar roles of substantia nigra and ventral tegmental dopamine neurons in reward and aversion. J Neurosci (2014) 1.30

Dual control of dopamine synthesis and release by presynaptic and postsynaptic dopamine D2 receptors. J Neurosci (2012) 1.29

Voluntary ethanol intake enhances excitatory synaptic strength in the ventral tegmental area. Alcohol Clin Exp Res (2008) 1.29

Synaptic plasticity in the mesolimbic system: therapeutic implications for substance abuse. Ann N Y Acad Sci (2010) 1.28

Reduced nucleus accumbens SK channel activity enhances alcohol seeking during abstinence. Neuron (2010) 1.27

Hypothalamic neurotensin projections promote reward by enhancing glutamate transmission in the VTA. J Neurosci (2013) 1.26

Motivation for alcohol becomes resistant to quinine adulteration after 3 to 4 months of intermittent alcohol self-administration. Alcohol Clin Exp Res (2010) 1.23

The sigma-1 receptor: roles in neuronal plasticity and disease. Trends Neurosci (2012) 1.22

Low dose nicotine treatment during early adolescence increases subsequent cocaine reward. Neurotoxicol Teratol (2006) 1.22

Effects of stress and aversion on dopamine neurons: implications for addiction. Neurosci Biobehav Rev (2010) 1.21

Time-dependent changes in proinflammatory and neurotrophic responses of microglia and astrocytes in a rat model of osmotic demyelination syndrome. Glia (2010) 1.20

Minocycline prevents osmotic demyelination syndrome by inhibiting the activation of microglia. J Am Soc Nephrol (2010) 1.20

Ethanol alters trafficking and functional N-methyl-D-aspartate receptor NR2 subunit ratio via H-Ras. J Biol Chem (2005) 1.18

The dopamine D2 receptor: new surprises from an old friend. Neuron (2005) 1.16

Tranylcypromine enhancement of nicotine self-administration. Neuropharmacology (2007) 1.13

Contrast enhancement: a physiological effect of striatal dopamine? Cell Tissue Res (2004) 1.12

Chronic cocaine enhances corticotropin-releasing factor-dependent potentiation of excitatory transmission in ventral tegmental area dopamine neurons. J Neurosci (2009) 1.11

Transient activation of specific neurons in mice by selective expression of the capsaicin receptor. Nat Commun (2012) 1.10

CRF acts in the midbrain to attenuate accumbens dopamine release to rewards but not their predictors. Nat Neurosci (2013) 1.09

Optogenetic modulation of neural circuits that underlie reward seeking. Biol Psychiatry (2011) 1.09

Methylphenidate facilitates learning-induced amygdala plasticity. Nat Neurosci (2010) 1.09

Glucocorticoids increase neuropeptide Y and agouti-related peptide gene expression via adenosine monophosphate-activated protein kinase signaling in the arcuate nucleus of rats. Endocrinology (2008) 1.09

Opioid-Induced GABA potentiation after chronic morphine attenuates the rewarding effects of opioids in the ventral tegmental area. J Neurosci (2010) 1.08

Sizing up ethanol-induced plasticity: the role of small and large conductance calcium-activated potassium channels. Alcohol Clin Exp Res (2009) 1.08

Negative allosteric modulation of nicotinic acetylcholine receptors blocks nicotine self-administration in rats. J Pharmacol Exp Ther (2007) 1.06

Urotensin II modulates rapid eye movement sleep through activation of brainstem cholinergic neurons. J Neurosci (2005) 1.05

Identification of precursor transcripts for 6 novel miRNAs expands the diversity on the genomic organisation and expression of miRNA genes in rice. BMC Plant Biol (2008) 1.02

The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders. Psychopharmacology (Berl) (2013) 1.02

Neural estimates of imagined outcomes in the orbitofrontal cortex drive behavior and learning. Neuron (2013) 1.01

Context-induced relapse to alcohol seeking after punishment in a rat model. Biol Psychiatry (2012) 1.01

Convergent actions of orexin/hypocretin and CRF on dopamine neurons: Emerging players in addiction. Brain Res (2009) 1.01

Impact of serotonin 2C receptor null mutation on physiology and behavior associated with nigrostriatal dopamine pathway function. J Neurosci (2009) 1.00

Monoamine oxidase inhibitors allow locomotor and rewarding responses to nicotine. Neuropsychopharmacology (2005) 1.00

Neuroplastic alterations in the limbic system following cocaine or alcohol exposure. Curr Top Behav Neurosci (2010) 1.00

A Drosophila adenosine receptor activates cAMP and calcium signaling. Insect Biochem Mol Biol (2007) 0.99

Adipose tissue-derived mesenchymal stem cell transplantation promotes hepatic regeneration after hepatic ischemia-reperfusion and subsequent hepatectomy in rats. J Surg Res (2012) 0.98

Recent updates on the melanin-concentrating hormone (MCH) and its receptor system: lessons from MCH1R antagonists. J Mol Neurosci (2010) 0.98

Novel therapeutic strategies for alcohol and drug addiction: focus on GABA, ion channels and transcranial magnetic stimulation. Neuropsychopharmacology (2011) 0.97

Acetaldehyde, a major constituent of tobacco smoke, enhances behavioral, endocrine, and neuronal responses to nicotine in adolescent and adult rats. Neuropsychopharmacology (2007) 0.97